معرفی
Dr. Stryder Meadows is an Associate Professor at Tulane University's School of Science & Engineering, focusing on vascular development and disease. He earned his Ph.D. from the University of Arizona in 2008 and leads a research group investigating molecular mechanisms underlying vascular disorders, particularly Hereditary Hemorrhagic Telangiectasia (HHT). His work integrates mouse genetics and in vitro approaches to explore arteriovenous malformations (AVMs) and identify TGFβ downstream targets.
Research Interests: Dr. Meadows' lab studies vascular biology, genetic disorders, and neurodevelopmental defects. Key areas include Zmiz1's role in brain development (linked to autism), CDK6-mediated vascular pathologies, and therapeutic strategies targeting ANG2 and PRDM16. His team uses mouse models to analyze cerebrovascular defects, retinal angiogenesis, and molecular pathways governing vascular identity.
Article Trends: Recent work emphasizes therapeutic advancements for HHT, novel regulators like Zmiz1 and PRDM16, and mechanistic insights into AVM formation. Publications span vascular biology, genetics, and translational medicine, with a focus on applying basic science to clinical challenges.
Labs & Teams: The Meadows Research Group at Tulane University employs interdisciplinary approaches, combining genetic, cellular, and imaging techniques. Collaborations focus on advancing understanding of vascular diseases and developing targeted therapies.
